Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses
Abstract Predictive biomarkers are important for selecting appropriate patients for particular treatments. Comprehensive genomic, transcriptomic, and pharmacological data provide clues for understanding relationships between biomarkers and drugs. However, it is still difficult to mine biologically m...
Guardado en:
Autores principales: | Naoya Fujita, Shinji Mizuarai, Katsuhiko Murakami, Kenta Nakai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f091510bcc004541819476ef898e5bff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pathway-based subnetworks enable cross-disease biomarker discovery
por: Syed Haider, et al.
Publicado: (2018) -
De novo mutational signature discovery in tumor genomes using SparseSignatures.
por: Avantika Lal, et al.
Publicado: (2021) -
Biomarker discovery in subclinical mycobacterial infections of cattle.
por: Meetu Seth, et al.
Publicado: (2009) -
Mutational signatures are jointly shaped by DNA damage and repair
por: Nadezda V. Volkova, et al.
Publicado: (2020) -
Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
por: Ji Young Kim, et al.
Publicado: (2017)